Form 8-K - Current report:
SEC Accession No. 0001604665-23-000004
Filing Date
2023-02-21
Accepted
2023-02-21 07:52:27
Documents
13
Period of Report
2023-02-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K wlkp-20230221.htm   iXBRL 8-K 36536
2 EX-99.1 ex991_221231earningsrelease.htm EX-99.1 213509
  Complete submission text file 0001604665-23-000004.txt   408516

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT wlkp-20230221.xsd EX-101.SCH 1915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT wlkp-20230221_lab.xml EX-101.LAB 25154
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT wlkp-20230221_pre.xml EX-101.PRE 13058
7 EXTRACTED XBRL INSTANCE DOCUMENT wlkp-20230221_htm.xml XML 12950
Mailing Address 2801 POST OAK BOULEVARD SUITE 600 HOUSTON TX 77056
Business Address 2801 POST OAK BOULEVARD SUITE 600 HOUSTON TX 77056 (713) 960-9111
Westlake Chemical Partners LP (Filer) CIK: 0001604665 (see all company filings)

EIN.: 320436529 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36567 | Film No.: 23645306
SIC: 2860 Industrial Organic Chemicals